Description
BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS.
First action · last action
2026-05-27 · 2026-05-27
Transactions
1
First transaction's obligation
$965,388
Base + all options value (sum of deltas)
$965,388
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24822A0030
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-05-27+$965,388= $965,388
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-05-27 | +$965,388 | $965,388 | BPA FOR ALINITY M SARS-COV-2/HIV REAGENTS. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6550 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826N0554 | AGILENT TECHNOLOGIES INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $35,634 | FY2026 |
| 36C24826N0393 | SYSMEX AMERICA, INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $340,032 | FY2026 |
| 36C24826A0019 | GOVERNMENT SCIENTIFIC SOURCE INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
| 36C24826N0602 | GOVERNMENT SCIENTIFIC SOURCE INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $579,998 | FY2026 |
| 36C24826N0363 | CEPHEID | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $997,200 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24826N0392_3600_36C24822A0030_3600 · retrieved 2026-09-26.